Historical Valuation
Mesoblast Ltd (MESO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 21.25 is considered Undervalued compared with the five-year average of -18.86. The fair price of Mesoblast Ltd (MESO) is between 219.29 to 244.28 according to relative valuation methord. Compared to the current price of 19.87 USD , Mesoblast Ltd is Undervalued By 90.94%.
Relative Value
Fair Zone
219.29-244.28
Current Price：19.87
90.94%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Mesoblast Ltd (MESO) has a current Price-to-Book (P/B) ratio of 38.91. Compared to its 3-year average P/B ratio of 12.03 , the current P/B ratio is approximately 223.41% higher. Relative to its 5-year average P/B ratio of 7.71, the current P/B ratio is about 404.31% higher. Mesoblast Ltd (MESO) has a Forward Free Cash Flow (FCF) yield of approximately -2.13%. Compared to its 3-year average FCF yield of -11.16%, the current FCF yield is approximately -80.93% lower. Relative to its 5-year average FCF yield of -11.91% , the current FCF yield is about -82.12% lower.
P/B
Median3y
12.03
Median5y
7.71
FCF Yield
Median3y
-11.16
Median5y
-11.91
Competitors Valuation Multiple
AI Analysis for MESO
The average P/S ratio for MESO competitors is 975.15, providing a benchmark for relative valuation. Mesoblast Ltd Corp (MESO.O) exhibits a P/S ratio of 21.25, which is -97.82% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for MESO
1Y
3Y
5Y
Market capitalization of MESO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of MESO in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is MESO currently overvalued or undervalued?
Mesoblast Ltd (MESO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 21.25 is considered Undervalued compared with the five-year average of -18.86. The fair price of Mesoblast Ltd (MESO) is between 219.29 to 244.28 according to relative valuation methord. Compared to the current price of 19.87 USD , Mesoblast Ltd is Undervalued By 90.94% .
What is Mesoblast Ltd (MESO) fair value?
MESO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Mesoblast Ltd (MESO) is between 219.29 to 244.28 according to relative valuation methord.
How does MESO's valuation metrics compare to the industry average?
The average P/S ratio for MESO's competitors is 975.15, providing a benchmark for relative valuation. Mesoblast Ltd Corp (MESO) exhibits a P/S ratio of 21.25, which is -97.82% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Mesoblast Ltd (MESO) as of Jan 09 2026?
As of Jan 09 2026, Mesoblast Ltd (MESO) has a P/B ratio of 38.91. This indicates that the market values MESO at 38.91 times its book value.
What is the current FCF Yield for Mesoblast Ltd (MESO) as of Jan 09 2026?
As of Jan 09 2026, Mesoblast Ltd (MESO) has a FCF Yield of -2.13%. This means that for every dollar of Mesoblast Ltd’s market capitalization, the company generates -2.13 cents in free cash flow.
What is the current Forward P/E ratio for Mesoblast Ltd (MESO) as of Jan 09 2026?
As of Jan 09 2026, Mesoblast Ltd (MESO) has a Forward P/E ratio of -194.58. This means the market is willing to pay $-194.58 for every dollar of Mesoblast Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Mesoblast Ltd (MESO) as of Jan 09 2026?
As of Jan 09 2026, Mesoblast Ltd (MESO) has a Forward P/S ratio of 21.25. This means the market is valuing MESO at $21.25 for every dollar of expected revenue over the next 12 months.